ROYAL BANK OF CANADA - APREA THERAPEUTICS INC ownership

APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 35 filers reported holding APREA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of APREA THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$22,000
-35.3%
11,7000.0%0.00%
Q4 2021$34,000
-67.6%
11,700
-43.2%
0.00%
Q3 2021$105,000
+1.0%
20,600
-2.6%
0.00%
Q2 2021$104,000
+36.8%
21,150
+39.4%
0.00%
Q1 2021$76,000
+81.0%
15,173
+76.5%
0.00%
Q4 2020$42,000
+55.6%
8,597
+675.9%
0.00%
Q3 2020$27,000
+125.0%
1,108
+268.1%
0.00%
Q2 2020$12,000
+1100.0%
301
+1154.2%
0.00%
Q1 2020$1,000
-85.7%
24
-83.9%
0.00%
Q4 2019$7,0001490.00%
Other shareholders
APREA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Versant Venture Management, LLC 1,259,662$6,437,0002.66%
COASTAL INVESTMENT MANAGEMENT, L.P. 41,965$214,0000.30%
Redmile Group, LLC 694,918$3,551,0000.06%
Quantamental Technologies LLC 13,752$70,0000.05%
KENNEDY CAPITAL MANAGEMENT LLC 342,486$1,750,0000.04%
PDT Partners, LLC 87,734$448,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 75,000$383,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 49,100$251,0000.01%
NEXT Financial Group, Inc 11,347$58,0000.01%
Sugarloaf Wealth Management, LLC 1,500$8,0000.00%
View complete list of APREA THERAPEUTICS INC shareholders